These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 8337028

  • 1. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
    Markowitz ME, Bijur PE, Ruff H, Rosen JF.
    Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
    [Abstract] [Full Text] [Related]

  • 2. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB, Anderson RL, Super DM.
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [Abstract] [Full Text] [Related]

  • 3. Trends in the management of childhood lead poisonings.
    Rosen JF, Markowitz ME.
    Neurotoxicology; 1993 Oct; 14(2-3):211-7. PubMed ID: 8247394
    [Abstract] [Full Text] [Related]

  • 4. Moderate lead poisoning: trends in blood lead levels in unchelated children.
    Markowitz ME, Bijur PE, Ruff HA, Balbi K, Rosen JF.
    Environ Health Perspect; 1996 Sep; 104(9):968-72. PubMed ID: 8899376
    [Abstract] [Full Text] [Related]

  • 5. Need for the lead mobilization test in children with lead poisoning.
    Markowitz ME, Rosen JF.
    J Pediatr; 1991 Aug; 119(2):305-10. PubMed ID: 1907320
    [Abstract] [Full Text] [Related]

  • 6. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S, Chaivisuth B, Siriratanapreuk S, Padungtod C, Pleubreukan R, Boonnark T, Worahan S, Bhumiratanarak P, Chomchai C.
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [Abstract] [Full Text] [Related]

  • 7. Is there lead in the suburbs? Risk assessment in Chicago suburban pediatric practices. Pediatric Practice Research Group.
    Binns HJ, LeBailly SA, Poncher J, Kinsella TR, Saunders SE.
    Pediatrics; 1994 Feb; 93(2):164-71. PubMed ID: 8121725
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels.
    Moel DI, Kumar K.
    Pediatrics; 1982 Aug; 70(2):259-62. PubMed ID: 7099793
    [Abstract] [Full Text] [Related]

  • 10. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS, Angle CR, Stohs SJ.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [Abstract] [Full Text] [Related]

  • 11. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF, Markowitz ME, Bijur PE, Jenks ST, Wielopolski L, Kalef-Ezra JA, Slatkin DN.
    Environ Health Perspect; 1991 Feb; 91():57-62. PubMed ID: 1904023
    [Abstract] [Full Text] [Related]

  • 12. Lead poisoning risk determination in an urban population through the use of a standardized questionnaire.
    Schaffer SJ, Szilagyi PG, Weitzman M.
    Pediatrics; 1994 Feb; 93(2):159-63. PubMed ID: 8121724
    [Abstract] [Full Text] [Related]

  • 13. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
    Graziano JH, Lolacono NJ, Moulton T, Mitchell ME, Slavkovich V, Zarate C.
    J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
    [Abstract] [Full Text] [Related]

  • 14. Management of children with slightly elevated blood lead levels.
    Kimbrough RD, LeVois M, Webb DR.
    Pediatrics; 1994 Feb; 93(2):188-91. PubMed ID: 8121729
    [Abstract] [Full Text] [Related]

  • 15. Removing lead from bone: clinical implications of bone lead stores.
    Wedeen RP.
    Neurotoxicology; 1992 Feb; 13(4):843-52. PubMed ID: 1302310
    [Abstract] [Full Text] [Related]

  • 16. Lightening the lead load in children.
    Ellis MR, Kane KY.
    Am Fam Physician; 2000 Aug 01; 62(3):545-54, 559-60. PubMed ID: 10950212
    [Abstract] [Full Text] [Related]

  • 17. Setting the optimal erythrocyte protoporphyrin screening decision threshold for lead poisoning: a decision analytic approach.
    DeBaun MR, Sox HC.
    Pediatrics; 1991 Jul 01; 88(1):121-31. PubMed ID: 2057248
    [Abstract] [Full Text] [Related]

  • 18. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
    Besunder JB, Super DM, Anderson RL.
    J Pediatr; 1997 Jun 01; 130(6):966-71. PubMed ID: 9202621
    [Abstract] [Full Text] [Related]

  • 19. Residential deleading: effects on the blood lead levels of lead-poisoned children.
    Amitai Y, Brown MJ, Graef JW, Cosgrove E.
    Pediatrics; 1991 Nov 01; 88(5):893-7. PubMed ID: 1945628
    [Abstract] [Full Text] [Related]

  • 20. Neuroendocrine effects of toxic and low blood lead levels in children.
    Huseman CA, Varma MM, Angle CR.
    Pediatrics; 1992 Aug 01; 90(2 Pt 1):186-9. PubMed ID: 1641279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.